May-Thurner Syndrome

Tuesday, 03/08/11 | 110399 reads
Author(s): 

Omar Al-Nouri, DO, MS and Ross Milner, MD

May-Thurner syndrome — also called iliocaval compression syndrome, Cockett syndrome or iliac vein compression syndrome — occurs secondary to compression of the left iliac vein by the overriding right iliac artery. Virchow was the first author to be credited with describing iliac vein compression. It was not until 1957 that May and Thurner brought much attention to the anatomic variant thought responsible for Virchow’s observation. They found that the right iliac artery compressed the left iliac vein against the fifth lumbar vertebra in 22–32% of 430 cadavers.1 These terms may be used interchangeably, but they all describe the phenomenon of left-sided vein compression by the right iliac artery causing left iliofemoral deep venous thrombosis (DVT).

Etiology and Incidence

The incidence of May-Thurner syndrome is unknown and ranges from 18–49% among patients with left-sided lower extremity DVT.2 Close to 600,000 hospitalizations occur in the United States each year due to DVT. DVT is more common in the left lower extremity than the right, and May-Thurner syndrome is considered to be a risk factor for patients with left-sided iliofemoral DVT. May and Thurner postulated that the chronic pulsations of the overriding right iliac artery led to the development of a “spur” in the vein wall, and that this spur would result in partial venous obstruction (Figure 1). Chronic trauma to the inner side of the vein wall due to adjacent arterial pulsations leads to the accumulation of elastin and collagen, contributing to spur formation.3 In addition to the chronic arterial pulsations, mechanic compression of the iliac vein by the thick-walled overriding iliac artery leads to extensive local intimal proliferation, impaired venous return and venous thrombosis.4 In addition to the mechanical alterations to the vessel wall, hypercoaguable states, when tested, are found in the majority of patients. Kolbel et al5 found underlying hypercoaguable disorders in 67% of patients screened prior to treatment of chronic iliac vein occlusion. Left iliac vein compression is the most common variant seen in May-Thurner syndrome; however, several other variants have been described in the literature. Compression of the left common iliac vein by the left internal iliac artery,6 compression of the right common iliac vein by the right internal iliac artery,7 compression of the inferior vena cava by the right common iliac artery8 and right-sided May-Thurner syndrome in a patient with a left-sided inferior vena cava9 have all been described.

Presentation

Patients with May-Thurner syndrome typically present with unilateral (left) lower extremity edema and pain. A propensity for this disorder is seen in young women in their second to fourth decade of life, after prolonged immobilization or pregnancy. Because of the chronic nature of the disease process, patients may also present with stigmata associated with post-thrombotic syndrome such as pigmentation changes, varicose veins, chronic leg pain, phlebitis and recurrent skin ulcers.4 The clinical stages of iliac vein compression were described by Kim et al,10 and include: Stage I, asymptomatic iliac vein compression; Stage II, development of a venous spur; Stage III, development of left iliac vein DVT.

Diagnosis

The diagnosis of May-Thurner syndrome is based on the clinical presentation of left lower extremity swelling and pain in association with radiologic evidence of compression. This being said, diagnosis of May-Thurner syndrome may not always be straightforward. Doppler ultrasound will detect if a DVT is present in the iliac vessels, but is unable to visualize iliac vein compression and spurs. Other diagnostic modalities include helical abdominal computed tomography (CT), CT venography, magnetic resonance venography (MRV), intravenous ultrasound (IVUS) and conventional venography. Kibbe et al11 used abdominal helical CT scanning to determine the incidence of left common iliac vein compression in an asymptomatic population (Figure 2). They found that two-thirds of all patients studied had at least 25% compression of the left iliac vein. The authors concluded that compression of the left iliac vein may be a normal anatomic finding, and that abdominal CT scanning is accurate in determining if left iliac vein compression is present. There are, however, limitations to the use of abdominal CT scanning in determining if iliac vein compression is present. The CT scans were obtained during the arterial phase of the intravenous bolus, which limits the type of vessel reconstruction and analysis that can be performed. CT venography may be used as an effective adjunctive modality when there is a known DVT. Chung et al12 found that CT venography was just as specific and highly sensitive in the diagnosis of DVT compared with ultrasound and accurately delineated venous anatomy and the extent of thrombus present. A limitation of CT venography involves the inability to control for the volume status of the patient, which could lead to overemphasis of the degree of compression of the left iliac vein in a dehydrated patient. The traditional “gold standard” for diagnosis of May-Thurner syndrome is conventional venography, which can be diagnostic and therapeutic when endovascular therapy is used (Figure 3.). Non-invasive imaging methods are being used increasingly to diagnose DVT and iliac compression. The aforementioned imaging modalities may help in planning catheter-directed thrombosis without the initial need for conventional venography. These non-invasive imaging modalities are simple, efficient and cost-effective in diagnosing DVT associated with iliac compression.3

Treatment Methods

May-Thurner syndrome patients are commonly asymptomatic, and it is therefore unrecognized until symptoms develop. Treatment of symptomatic May-Thurner syndrome has evolved over the years from traditional open repair to less invasive endovascular repair. Treatment is aimed at clearing the thrombus present to prevent post-thrombotic syndrome and to correct the underlying compression of the left iliac vein. Untreated, a significant majority of adults with May-Thurner syndrome and thrombosis develop debilitating post-thrombotic syndrome.13 Historically, several surgical procedures have been used to ameliorate symptoms and correct the underlying compression such as venovenous bypass with autologous vein, creation of a tissue sling to elevate the overriding right iliac artery, retropositioning of the iliac artery and excision of the intraluminal spur with patch venoplasty. Traditional open repair has yielded variable results, and with the advent of endovascular technology and technique, mainstay therapy now includes a combination of surgical and endovascular approaches.

The first known report of treatment of May-Thurner syndrome solely by endovascular means was by Berger14 et al in 1995, who successfully placed a venous stent to relieve iliac compression. Several subsequent studies have demonstrated efficacy in the treatment of iliac vein compression with thrombectomy and endovascular stenting.15,16 The initial treatment of patients with documented iliofemoral thrombosis in the setting of iliac vein compression is to decrease the clot burden by use of thrombectomy. Traditionally, surgical thrombectomy alone was used. However, if a stent was not placed subsequently, reocclusion occurred in approximately 70% of patients treated.17 Catheter-directed thrombolysis with urokinase or t-PA is very effective in reducing clot burden by dissolving the thrombus present (Figure 4). Localized thrombolytic therapy is commonly performed to decrease the risk of major bleeding that can be seen with the use of systemic thrombolytic therapy. Alternatively, mechanical thrombolysis has been used to reduce lytic infusion time and complications. Following thrombectomy, angioplasty with stent placement is used to correct the venous obstruction. Stent implantation versus angioplasty alone is more effective in relieving venous obstruction.18 Recanalization of the involved segment involves passing a wire through the occlusion and in general predilating the vessel. Self-expandable stents are used in the venous system as they can cover long distances, are easy to re-sheath and have adequate durability. Balloon-expandable stents may be used if needed (insufficient response to predilatation/self-expandable stent). Extending the stent into the inferior vena cava (IVC) may be done without increasing the risk of contralateral iliac vein occlusion.19 However, some studies have found that extending the iliac stent below the inguinal ligament in the common femoral vein to ensure venous inflow could increase the risk of in-stent restenosis.20,21 These results, though, have been controversial and there is to date no consensus on the risk of venous stenting below the inguinal ligament. Long-term 5-year patency rates for patients undergoing stent implantation range from 74–80%.5,21 Patency can be affected by the amount of occlusion in the iliac vein. Patients who have chronic complete occlusion (as in patients with May-Thurner) have lower patency rates when compared to those with just stenotic obstructions.20 This has led to an increase in combined surgical and endovascular approaches for patients with complete venous occlusions in the late 1990s and early 2000. Surgical intervention typically involved common femoral venectomy, complete thrombus removal with stent placement. The results shown by Kolbel et al5 and Wahlgren et al22 have shown that now similar results can be accomplished with endovascular stenting alone. Several complications occur with endovascular stenting including stent migration, stent fracture, retroperitoneal hemorrhage and early in-stent thrombosis. Patients are routinely anticoagulated following thrombectomy and venous stent placement for up to 6 months to minimize in-stent restenosis. There are several factors associated with in-stent restenosis, despite the use of anticoagulation, which include recent trauma, thrombotic disease, thrombophilia and stenting below the inguinal ligament.23

Conclusion

May-Thurner syndrome continues to challenge medical practitioners to this day. It can have debilitating sequelae resulting from post-thrombotic syndrome. More and more, helical CT scanning is becoming the standard for diagnosis of iliofemoral vein thrombosis. Management of May-Thurner syndrome has evolved over the past few decades favoring endovascular management as the primary treatment. With early recognition and aggressive management, May-Thurner syndrome can be a well-managed disease.

References

1. May R, Thurner J. The cause of the predominately sinistral occurrence of thrombosis of the pelvic veins. Angiology 1957;8:419–427.
2. Kasirajan K, Gray B, Ouriel K. Percutaneous angiojet thrombectomy in the management of extensive deep vein thrombosis. J Vasc Interv Radiol 2001;12:179–185.
3. Oguzkurt L, Ozkan U, Tercan F, Koc Z. Ultrasonographic diagnosis of iliac vein compression (May-Thurner) syndrome. Diag Interv Radiol 2007;13:152–155.
4. Baron HC, Sharms J, Wayne M. Iliac vein compression syndrome: A new method of treatment. Am Surg 2000;66:653–655.
5. Kolbel T et al. Chronic iliac vein occlusion: Midterm results of endovascular recanalization. J Endovasc Ther 2009;16:483–491.
6. Dheer S, Joseph AE, Drooz A. Retroperitoneal hematoma caused by a ruptured pelvic varix in a patient with iliac vein compression syndrome. J Vasc Interv Radiol 2003;14:387–390.
7. Molloy S, Jacob S, Buckenham T, et al. Arterial compression of the right common iliac vein: An unusual anatomic variant. Cardiovasc Surg 2002;10:291–292.
8. Fretz V, Binkert A. Compression of the Inferior vena cava by the right iliac artery: A rare variant of May-Thurner syndrome. Cardiovasc Intervent Radiol 2010;33:1060–1063.
9. Burke RM, Rayan SS, Kasirajan K, et al. Unusual case of right-sided May-Thurner syndrome and review of its management. Vascular 2006;14:47–50.
10. Kim D, Orron DE, Porter DH. Venographic anatomy, technique and interpretation. In: Kim D, Orron DE (eds.) Peripheral Vascular Imaging and Intervention. St Louis (Missouri); Mosby-Year Book; 1992, pp 269–349.
11. Kibbe MR, Ujiki M, Goodwin A, et al. Iliac vein compression in an asymptomaticpatient population. J Vasc Surg 2004;937–943.
12. Chung JW, Yoon CJ, Jung SI, et al. Acute iliofemoral deep vein thrombosis: Evaluation of underlying anatomic abdnormalities by spiral CT venography. J Vasc Interv Radiol 2004;15:249–256.
13. Raffini L, Raybagkar D, Cahill AM, et al. May-Thurner syndrome (iliac vein compression) and thrombosis in adolescents. Pediatr Blood Cancer 2006;47:834–838.
14. Berger A, Jaffe JW, York TN. Iliac compression syndrome treated with stent placement. J Vasc Surg 1995;21:510–514.
15. O’Sullivan GJ, Semba CP, Bittner CA, et al. Endovascular management of iliac veincompression (May-Thurner) syndrome. J Vasc Intervent Radiol 2000;11:823–836.
16. Schwarzbach MH, Schumacher H, Böckler D, et al. Surgical thrombectomy followed by intraoperative endovascular reconstruction for symptomatic ilio-femoral venous thrombosis. Eur J Vasc Endovasc Surg 2005;29:58–66.
17. Mickley V, Schwagierek R, Rilinger N, et al. Left iliac venous thrombosis caused by venous spur: Treatment with thrombectomy and stent implantation. J Vasc Surg 1998;28:492–497.
18. Whittemore AD, Donaldson MC, Polak JF, Mannick JA. Limitations of balloon angioplasty for vein graft stenosis. J Vasc Surg 1991;14:340–345.
19. Neglen P, Hollis KC, Olivier J, Raju S. Stenting of the venous outflow in chronic venous in chronic venous disease: Long-term stent-related outcome, clinical and hemodynamic result. J Vasc Surg 2007;46:979–990.
20. Neglen P, Tackett TP, Raju S. Venous stenting across the inguinal ligament. J Vasc Surg 2008;48:1255–1261.
21. Hood DB, Alexander JQ. Endovascular management of iliofemoral venous occlusive disease. Surg Clin North Am 2004;84:1381–1396.
22. Wahlgren CM, Wahlberg E, Olofsson P. Endovascular treatment in postthrombotic syndrome. Vasc and Endovasc Surg 2010;44:356–360.
23. Knipp et al. Factors associated with outcome after interventional treatment of symptomatic iliac vein compression syndrome. J Vasc Surg 2007;46:743–748.

___________________________________________________________________

Omar Al-Nouri, DO, MS* and Ross Milner, MD§

From the *Department of Surgery and the §Department of Vascular and Endovascular Surgery, Loyola University Medical Center, Maywood, Illinois.

The authors report no conflicts of interest regarding the content herein.

Address for correspondence: Al-Nouri, DO, MS, Loyola University Medical Center, 2160 S. First Avenue, Maywood, IL 60153.

Clinical Review

Comments

Hi all. I was diagnosed in Dec 2012 - Merry Christmas. Thankfully, I had a PCP who sent me to vascular - and 2 days after my initial appointment with him - I was in the angio suite for thrombolysis, with a second venogram the next day for stent placement after spending the night in the ICU on clot dissolving drugs. Onset of symptoms was fast, with my leg twice the size of my right, and a lot of pain (worse than breaking my knee). My clot was massive and occlusive, stretching from the iliac vein to my foot. It was bad enough to start developing a venous stasis ulcer within 3 days of onset of symptoms. I almost lost my leg. I am a nurse and spent 15 years working ICU's, so being in the ICU as a patient let me realize how serious my condition was. So far, I was able to come off plavix last week, and if my next studies are clear, I can come off the blood thinners. I do get occassional mildly painful twinges (I have a very high pain tolerance) on the left side of my abdomen, so that gives me a little concern about keeping my stent open and flowing well. Swelling has not been a problem since stent was placed, and I went through a lot of expensive compression hose to find a comfortable and good fit.

I was diagnosed today (11/25/13) with MTS. About 7-10 years ago I began asking doctors about the discoloration on my lower left leg. Nobody knew what it was. It's been a long, painful process. Anyway, the stenting procedure is scheduled for next month and I'm trying to find out as much as I can about what to expect. You mentioned compression hose in your comment and I'm wondering if you/I have to wear them for the rest of our lives or is it only for a while after surgery?

I had a stent put in back in August 2013 for MTS. For me, the swelling in my left foot/ankle has been reduced about 50%. I have been told to continue to wear my compression stocking as needed. I am hoping that over time I will be able to stop wearing it, but I believe that permanent tissue damage was done. I lived with MTS for about 6 years before I was properly diagnosed.

Hi Lee, I was recently diagnosed with mts just two days ago. I have been wearing compression stockings since 2001 at the first onset of a DVT. For me too this is a painful process. I will be having surgery in the near future.How did your stenting process and surgery go?

Hi. I have just recently been diagnosed with MTS after 12 years of being told by many specialists and 4 DVT's later that I need to be on aspirin for the rest of my life and wear compression stockings. Then I started to develop an ulcer at the most distal part of my foot that was getting infected every couple of weeks. My leg started to swell and then a Vascular Surgeon suggested that I may have MTS. Following all the relevant tests it was in fact MTS. I have just had 60mm stent put in my illiac vein. I have been told the stent cannot ever be removed if it doesn't work however it will last awhile if it does. The only symptom that I have post op is the lower lumber pressure I experienced during the ballooning process whilst in the operating theatre. Can anyone tell me if that pressure disappears after a while.

I am currently helping someone with May-Thurner syndrome appeal a disability denial. I was wanting to gather a little more information on the condition. First, can it be caused by intravenous drug use? Also, has anyone had experience with obtaining disability with May-Thurner syndrome? I need some information that will help me appeal for my client.

Add new comment

Back to top

May-Thurner Syndrome

Tuesday, 03/08/11 | 110399 reads
Author(s): 

Omar Al-Nouri, DO, MS and Ross Milner, MD

May-Thurner syndrome — also called iliocaval compression syndrome, Cockett syndrome or iliac vein compression syndrome — occurs secondary to compression of the left iliac vein by the overriding right iliac artery. Virchow was the first author to be credited with describing iliac vein compression. It was not until 1957 that May and Thurner brought much attention to the anatomic variant thought responsible for Virchow’s observation. They found that the right iliac artery compressed the left iliac vein against the fifth lumbar vertebra in 22–32% of 430 cadavers.1 These terms may be used interchangeably, but they all describe the phenomenon of left-sided vein compression by the right iliac artery causing left iliofemoral deep venous thrombosis (DVT).

Etiology and Incidence

The incidence of May-Thurner syndrome is unknown and ranges from 18–49% among patients with left-sided lower extremity DVT.2 Close to 600,000 hospitalizations occur in the United States each year due to DVT. DVT is more common in the left lower extremity than the right, and May-Thurner syndrome is considered to be a risk factor for patients with left-sided iliofemoral DVT. May and Thurner postulated that the chronic pulsations of the overriding right iliac artery led to the development of a “spur” in the vein wall, and that this spur would result in partial venous obstruction (Figure 1). Chronic trauma to the inner side of the vein wall due to adjacent arterial pulsations leads to the accumulation of elastin and collagen, contributing to spur formation.3 In addition to the chronic arterial pulsations, mechanic compression of the iliac vein by the thick-walled overriding iliac artery leads to extensive local intimal proliferation, impaired venous return and venous thrombosis.4 In addition to the mechanical alterations to the vessel wall, hypercoaguable states, when tested, are found in the majority of patients. Kolbel et al5 found underlying hypercoaguable disorders in 67% of patients screened prior to treatment of chronic iliac vein occlusion. Left iliac vein compression is the most common variant seen in May-Thurner syndrome; however, several other variants have been described in the literature. Compression of the left common iliac vein by the left internal iliac artery,6 compression of the right common iliac vein by the right internal iliac artery,7 compression of the inferior vena cava by the right common iliac artery8 and right-sided May-Thurner syndrome in a patient with a left-sided inferior vena cava9 have all been described.

Presentation

Patients with May-Thurner syndrome typically present with unilateral (left) lower extremity edema and pain. A propensity for this disorder is seen in young women in their second to fourth decade of life, after prolonged immobilization or pregnancy. Because of the chronic nature of the disease process, patients may also present with stigmata associated with post-thrombotic syndrome such as pigmentation changes, varicose veins, chronic leg pain, phlebitis and recurrent skin ulcers.4 The clinical stages of iliac vein compression were described by Kim et al,10 and include: Stage I, asymptomatic iliac vein compression; Stage II, development of a venous spur; Stage III, development of left iliac vein DVT.

Diagnosis

The diagnosis of May-Thurner syndrome is based on the clinical presentation of left lower extremity swelling and pain in association with radiologic evidence of compression. This being said, diagnosis of May-Thurner syndrome may not always be straightforward. Doppler ultrasound will detect if a DVT is present in the iliac vessels, but is unable to visualize iliac vein compression and spurs. Other diagnostic modalities include helical abdominal computed tomography (CT), CT venography, magnetic resonance venography (MRV), intravenous ultrasound (IVUS) and conventional venography. Kibbe et al11 used abdominal helical CT scanning to determine the incidence of left common iliac vein compression in an asymptomatic population (Figure 2). They found that two-thirds of all patients studied had at least 25% compression of the left iliac vein. The authors concluded that compression of the left iliac vein may be a normal anatomic finding, and that abdominal CT scanning is accurate in determining if left iliac vein compression is present. There are, however, limitations to the use of abdominal CT scanning in determining if iliac vein compression is present. The CT scans were obtained during the arterial phase of the intravenous bolus, which limits the type of vessel reconstruction and analysis that can be performed. CT venography may be used as an effective adjunctive modality when there is a known DVT. Chung et al12 found that CT venography was just as specific and highly sensitive in the diagnosis of DVT compared with ultrasound and accurately delineated venous anatomy and the extent of thrombus present. A limitation of CT venography involves the inability to control for the volume status of the patient, which could lead to overemphasis of the degree of compression of the left iliac vein in a dehydrated patient. The traditional “gold standard” for diagnosis of May-Thurner syndrome is conventional venography, which can be diagnostic and therapeutic when endovascular therapy is used (Figure 3.). Non-invasive imaging methods are being used increasingly to diagnose DVT and iliac compression. The aforementioned imaging modalities may help in planning catheter-directed thrombosis without the initial need for conventional venography. These non-invasive imaging modalities are simple, efficient and cost-effective in diagnosing DVT associated with iliac compression.3

Treatment Methods

May-Thurner syndrome patients are commonly asymptomatic, and it is therefore unrecognized until symptoms develop. Treatment of symptomatic May-Thurner syndrome has evolved over the years from traditional open repair to less invasive endovascular repair. Treatment is aimed at clearing the thrombus present to prevent post-thrombotic syndrome and to correct the underlying compression of the left iliac vein. Untreated, a significant majority of adults with May-Thurner syndrome and thrombosis develop debilitating post-thrombotic syndrome.13 Historically, several surgical procedures have been used to ameliorate symptoms and correct the underlying compression such as venovenous bypass with autologous vein, creation of a tissue sling to elevate the overriding right iliac artery, retropositioning of the iliac artery and excision of the intraluminal spur with patch venoplasty. Traditional open repair has yielded variable results, and with the advent of endovascular technology and technique, mainstay therapy now includes a combination of surgical and endovascular approaches.

The first known report of treatment of May-Thurner syndrome solely by endovascular means was by Berger14 et al in 1995, who successfully placed a venous stent to relieve iliac compression. Several subsequent studies have demonstrated efficacy in the treatment of iliac vein compression with thrombectomy and endovascular stenting.15,16 The initial treatment of patients with documented iliofemoral thrombosis in the setting of iliac vein compression is to decrease the clot burden by use of thrombectomy. Traditionally, surgical thrombectomy alone was used. However, if a stent was not placed subsequently, reocclusion occurred in approximately 70% of patients treated.17 Catheter-directed thrombolysis with urokinase or t-PA is very effective in reducing clot burden by dissolving the thrombus present (Figure 4). Localized thrombolytic therapy is commonly performed to decrease the risk of major bleeding that can be seen with the use of systemic thrombolytic therapy. Alternatively, mechanical thrombolysis has been used to reduce lytic infusion time and complications. Following thrombectomy, angioplasty with stent placement is used to correct the venous obstruction. Stent implantation versus angioplasty alone is more effective in relieving venous obstruction.18 Recanalization of the involved segment involves passing a wire through the occlusion and in general predilating the vessel. Self-expandable stents are used in the venous system as they can cover long distances, are easy to re-sheath and have adequate durability. Balloon-expandable stents may be used if needed (insufficient response to predilatation/self-expandable stent). Extending the stent into the inferior vena cava (IVC) may be done without increasing the risk of contralateral iliac vein occlusion.19 However, some studies have found that extending the iliac stent below the inguinal ligament in the common femoral vein to ensure venous inflow could increase the risk of in-stent restenosis.20,21 These results, though, have been controversial and there is to date no consensus on the risk of venous stenting below the inguinal ligament. Long-term 5-year patency rates for patients undergoing stent implantation range from 74–80%.5,21 Patency can be affected by the amount of occlusion in the iliac vein. Patients who have chronic complete occlusion (as in patients with May-Thurner) have lower patency rates when compared to those with just stenotic obstructions.20 This has led to an increase in combined surgical and endovascular approaches for patients with complete venous occlusions in the late 1990s and early 2000. Surgical intervention typically involved common femoral venectomy, complete thrombus removal with stent placement. The results shown by Kolbel et al5 and Wahlgren et al22 have shown that now similar results can be accomplished with endovascular stenting alone. Several complications occur with endovascular stenting including stent migration, stent fracture, retroperitoneal hemorrhage and early in-stent thrombosis. Patients are routinely anticoagulated following thrombectomy and venous stent placement for up to 6 months to minimize in-stent restenosis. There are several factors associated with in-stent restenosis, despite the use of anticoagulation, which include recent trauma, thrombotic disease, thrombophilia and stenting below the inguinal ligament.23

Conclusion

May-Thurner syndrome continues to challenge medical practitioners to this day. It can have debilitating sequelae resulting from post-thrombotic syndrome. More and more, helical CT scanning is becoming the standard for diagnosis of iliofemoral vein thrombosis. Management of May-Thurner syndrome has evolved over the past few decades favoring endovascular management as the primary treatment. With early recognition and aggressive management, May-Thurner syndrome can be a well-managed disease.

References

1. May R, Thurner J. The cause of the predominately sinistral occurrence of thrombosis of the pelvic veins. Angiology 1957;8:419–427.
2. Kasirajan K, Gray B, Ouriel K. Percutaneous angiojet thrombectomy in the management of extensive deep vein thrombosis. J Vasc Interv Radiol 2001;12:179–185.
3. Oguzkurt L, Ozkan U, Tercan F, Koc Z. Ultrasonographic diagnosis of iliac vein compression (May-Thurner) syndrome. Diag Interv Radiol 2007;13:152–155.
4. Baron HC, Sharms J, Wayne M. Iliac vein compression syndrome: A new method of treatment. Am Surg 2000;66:653–655.
5. Kolbel T et al. Chronic iliac vein occlusion: Midterm results of endovascular recanalization. J Endovasc Ther 2009;16:483–491.
6. Dheer S, Joseph AE, Drooz A. Retroperitoneal hematoma caused by a ruptured pelvic varix in a patient with iliac vein compression syndrome. J Vasc Interv Radiol 2003;14:387–390.
7. Molloy S, Jacob S, Buckenham T, et al. Arterial compression of the right common iliac vein: An unusual anatomic variant. Cardiovasc Surg 2002;10:291–292.
8. Fretz V, Binkert A. Compression of the Inferior vena cava by the right iliac artery: A rare variant of May-Thurner syndrome. Cardiovasc Intervent Radiol 2010;33:1060–1063.
9. Burke RM, Rayan SS, Kasirajan K, et al. Unusual case of right-sided May-Thurner syndrome and review of its management. Vascular 2006;14:47–50.
10. Kim D, Orron DE, Porter DH. Venographic anatomy, technique and interpretation. In: Kim D, Orron DE (eds.) Peripheral Vascular Imaging and Intervention. St Louis (Missouri); Mosby-Year Book; 1992, pp 269–349.
11. Kibbe MR, Ujiki M, Goodwin A, et al. Iliac vein compression in an asymptomaticpatient population. J Vasc Surg 2004;937–943.
12. Chung JW, Yoon CJ, Jung SI, et al. Acute iliofemoral deep vein thrombosis: Evaluation of underlying anatomic abdnormalities by spiral CT venography. J Vasc Interv Radiol 2004;15:249–256.
13. Raffini L, Raybagkar D, Cahill AM, et al. May-Thurner syndrome (iliac vein compression) and thrombosis in adolescents. Pediatr Blood Cancer 2006;47:834–838.
14. Berger A, Jaffe JW, York TN. Iliac compression syndrome treated with stent placement. J Vasc Surg 1995;21:510–514.
15. O’Sullivan GJ, Semba CP, Bittner CA, et al. Endovascular management of iliac veincompression (May-Thurner) syndrome. J Vasc Intervent Radiol 2000;11:823–836.
16. Schwarzbach MH, Schumacher H, Böckler D, et al. Surgical thrombectomy followed by intraoperative endovascular reconstruction for symptomatic ilio-femoral venous thrombosis. Eur J Vasc Endovasc Surg 2005;29:58–66.
17. Mickley V, Schwagierek R, Rilinger N, et al. Left iliac venous thrombosis caused by venous spur: Treatment with thrombectomy and stent implantation. J Vasc Surg 1998;28:492–497.
18. Whittemore AD, Donaldson MC, Polak JF, Mannick JA. Limitations of balloon angioplasty for vein graft stenosis. J Vasc Surg 1991;14:340–345.
19. Neglen P, Hollis KC, Olivier J, Raju S. Stenting of the venous outflow in chronic venous in chronic venous disease: Long-term stent-related outcome, clinical and hemodynamic result. J Vasc Surg 2007;46:979–990.
20. Neglen P, Tackett TP, Raju S. Venous stenting across the inguinal ligament. J Vasc Surg 2008;48:1255–1261.
21. Hood DB, Alexander JQ. Endovascular management of iliofemoral venous occlusive disease. Surg Clin North Am 2004;84:1381–1396.
22. Wahlgren CM, Wahlberg E, Olofsson P. Endovascular treatment in postthrombotic syndrome. Vasc and Endovasc Surg 2010;44:356–360.
23. Knipp et al. Factors associated with outcome after interventional treatment of symptomatic iliac vein compression syndrome. J Vasc Surg 2007;46:743–748.

___________________________________________________________________

Omar Al-Nouri, DO, MS* and Ross Milner, MD§

From the *Department of Surgery and the §Department of Vascular and Endovascular Surgery, Loyola University Medical Center, Maywood, Illinois.

The authors report no conflicts of interest regarding the content herein.

Address for correspondence: Al-Nouri, DO, MS, Loyola University Medical Center, 2160 S. First Avenue, Maywood, IL 60153.

Clinical Review

Comments

Hi all. I was diagnosed in Dec 2012 - Merry Christmas. Thankfully, I had a PCP who sent me to vascular - and 2 days after my initial appointment with him - I was in the angio suite for thrombolysis, with a second venogram the next day for stent placement after spending the night in the ICU on clot dissolving drugs. Onset of symptoms was fast, with my leg twice the size of my right, and a lot of pain (worse than breaking my knee). My clot was massive and occlusive, stretching from the iliac vein to my foot. It was bad enough to start developing a venous stasis ulcer within 3 days of onset of symptoms. I almost lost my leg. I am a nurse and spent 15 years working ICU's, so being in the ICU as a patient let me realize how serious my condition was. So far, I was able to come off plavix last week, and if my next studies are clear, I can come off the blood thinners. I do get occassional mildly painful twinges (I have a very high pain tolerance) on the left side of my abdomen, so that gives me a little concern about keeping my stent open and flowing well. Swelling has not been a problem since stent was placed, and I went through a lot of expensive compression hose to find a comfortable and good fit.

I was diagnosed today (11/25/13) with MTS. About 7-10 years ago I began asking doctors about the discoloration on my lower left leg. Nobody knew what it was. It's been a long, painful process. Anyway, the stenting procedure is scheduled for next month and I'm trying to find out as much as I can about what to expect. You mentioned compression hose in your comment and I'm wondering if you/I have to wear them for the rest of our lives or is it only for a while after surgery?

I had a stent put in back in August 2013 for MTS. For me, the swelling in my left foot/ankle has been reduced about 50%. I have been told to continue to wear my compression stocking as needed. I am hoping that over time I will be able to stop wearing it, but I believe that permanent tissue damage was done. I lived with MTS for about 6 years before I was properly diagnosed.

Hi Lee, I was recently diagnosed with mts just two days ago. I have been wearing compression stockings since 2001 at the first onset of a DVT. For me too this is a painful process. I will be having surgery in the near future.How did your stenting process and surgery go?

Hi. I have just recently been diagnosed with MTS after 12 years of being told by many specialists and 4 DVT's later that I need to be on aspirin for the rest of my life and wear compression stockings. Then I started to develop an ulcer at the most distal part of my foot that was getting infected every couple of weeks. My leg started to swell and then a Vascular Surgeon suggested that I may have MTS. Following all the relevant tests it was in fact MTS. I have just had 60mm stent put in my illiac vein. I have been told the stent cannot ever be removed if it doesn't work however it will last awhile if it does. The only symptom that I have post op is the lower lumber pressure I experienced during the ballooning process whilst in the operating theatre. Can anyone tell me if that pressure disappears after a while.

I am currently helping someone with May-Thurner syndrome appeal a disability denial. I was wanting to gather a little more information on the condition. First, can it be caused by intravenous drug use? Also, has anyone had experience with obtaining disability with May-Thurner syndrome? I need some information that will help me appeal for my client.

Add new comment

Back to top